Skip to main content
Hit enter to search or ESC to close
Close Search
RIS RxRIS Rx
Menu
  • Our Platform
  • Insights
  • Our Story
  • Get My GTN Assessment

    Gerald Bortis

    Chief Technology Officer
    Gerald Bortis

    Gerald Bortis

    Chief Technology Officer

    Gerald serves as Chief Technology Officer at RIS Rx, leading the development of the platform that enables real-time gross-to-net (GTN) revenue protection for the world's leading pharmaceutical manufacturers. He brings extensive software engineering leadership experience, having developed scalable, data-driven systems within healthcare technology at organizations such as Avaneer Health, NextGen Healthcare, and Mirth. Gerald holds Bachelor's, Master's, and PhD degrees in Software Engineering from the University of California, Irvine.

    Learn why the world's top pharmaceutical companies trust RIS Rx to protect their patients and improve GTN.

    "*" indicates required fields

    Consent*
    GTN areas I‘d like to explore:
    • Our Platform
    • Insights
    • Our Story
    • Contact
    • Careers
    • Press
    Get My GTN Assessment

    RIS Rx offers real-time GTN Revenue Protection to the world's leading pharmaceutical manufacturers, ensuring that every dollar allocated for affordability reaches the right patient at the right time.

    • Sitemap
    • Terms of Use
    • Privacy Policy
    • Cookie Settings
    • Do Not Sell My Personal Information
    Close Menu
    • Our Platform
    • Insights
    • Our Story
    • Get Assessment

    RIS Rx is pioneering real-time GTN Revenue Protection for the world's leading pharmaceutical manufacturers, ensuring that every dollar allocated for affordability reaches the right patients at the right time.